Serina Therapeutics (SER) Interest & Investment Income (2018 - 2022)
Serina Therapeutics' (SER) quarterly Interest & Investment Income came in at -$863000.0 in Q2 2022, down 214.96% year-over-year from $750673.0 in Q2 2021, and down 51.14% quarter-over-quarter from -$571000.0 in Q1 2022.
Powered by 
Analysis
Serina Therapeutics (SER) Interest & Investment Income (2018 - 2022) Analysis & Trends
Serina Therapeutics has disclosed Interest & Investment Income across 5 years of filings, most recently posting -$863000.0 for Q2 2022.
- In Q2 2022, Interest & Investment Income fell 214.96% year-over-year to -$863000.0; the TTM figure through Jun 2022 stood at -$2.0 million (down 143.83% YoY), while the FY2021 annual figure was -$1.1 million, down 171.53% from the prior year.
- Interest & Investment Income came in at -$863000.0 for Q2 2022 at Serina Therapeutics, down from -$571000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $39000.0 in Q3 2018 to a low of -$863000.0 in Q2 2022.
- Average Interest & Investment Income over 5 years is -$165176.5, with a median of -$65000.0 recorded in 2020.
- Year-over-year, Interest & Investment Income advanced 22.22% in 2019 and slumped 1687.5% in 2020.
- Over 5 years, Interest & Investment Income stood at $32000.0 in 2018, then tumbled by 175.0% to -$24000.0 in 2019, then slumped by 658.33% to -$182000.0 in 2020, then slumped by 62.09% to -$295000.0 in 2021, then slumped by 192.54% to -$863000.0 in 2022.
- Per Business Quant data, the three most recent Interest & Investment Income figures were -$863000.0 in Q2 2022, -$571000.0 in Q1 2022, and -$295000.0 in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 120.60 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -48.00 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 48.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 67.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 36.92 Mn |
| 10 | Serina Therapeutics | 40.47 Mn | 17.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | -863,000.00 |
| Mar 31, 2022 | -571,000.00 |
| Dec 31, 2021 | -295,000.00 |
| Sep 30, 2021 | -285,000.00 |
| Jun 30, 2021 | -274,000.00 |
| Mar 31, 2021 | -243,000.00 |
| Dec 31, 2020 | -182,000.00 |
| Sep 30, 2020 | -127,000.00 |
| Jun 30, 2020 | -65,000.00 |
| Mar 31, 2020 | -30,000.00 |
| Dec 31, 2019 | -24,000.00 |
| Sep 30, 2019 | 8,000.00 |
| Jun 30, 2019 | 33,000.00 |
| Mar 31, 2019 | 12,000.00 |
| Dec 31, 2018 | 32,000.00 |
| Sep 30, 2018 | 39,000.00 |
| Jun 30, 2018 | 27,000.00 |